Quick verdict: ACN vs APH in 2026

Accenture (ACN) appears to hold a significant overall edge in this 2026 comparison, demonstrating stronger valuation metrics and a more favorable analyst outlook. While Amphenol (APH) boasts superior revenue growth and profitability margins, ACN presents a more compelling investment from a value perspective with greater projected upside. Analysts show a clear preference for ACN, reinforcing its position as the stock with the most potential upside according to current targets. Not investment advice.

ACN vs APH: key metrics side by side

Full side-by-side comparison of ACN and APH across valuation, profitability, growth and analyst sentiment. Data updated 2026-04-17.

ACN vs APH valuation comparison

When assessing ACN vs APH valuation, Accenture plc (ACN) clearly stands out as the more attractively priced option in 2026. ACN trades at a modest P/E ratio of 15.58x, a stark contrast to Amphenol Corporation’s (APH) considerably higher P/E of 42.75x. This wide divergence suggests that investors are currently paying a much lower premium for ACN’s earnings compared to APH, which implies ACN offers greater relative value. Furthermore, examining the price-to-book (P/B) ratio reinforces this perspective, with ACN at 3.84x versus APH at 13.61x, indicating that ACN’s market value is closer to its book value.

The discounted cash flow (DCF) analysis further solidifies ACN’s valuation advantage. ACN’s current price of $194 implies an upside potential of +10.4% based on its DCF estimate of $214.13. Conversely, APH, priced at $148.96, appears significantly overvalued by its DCF model, which suggests a fair value of $85.04, representing a substantial downside of -42.9%. This critical metric strongly suggests that ACN offers a better margin of safety and potential for capital appreciation based on intrinsic value, making it the cheaper option from a fundamental valuation standpoint.

ACN vs APH growth comparison

In terms of growth, Amphenol Corporation (APH) demonstrates significantly stronger momentum compared to Accenture plc (ACN) as of 2026. APH reported an impressive year-over-year revenue growth of +51.7%, showcasing robust expansion and demand for its products and services. This substantial growth rate positions APH as a clear leader for investors prioritizing rapid top-line expansion. In contrast, ACN posted a more moderate revenue growth of +7.4%, which, while respectable for a company of its scale, does not match APH’s explosive performance.

Beyond top-line revenue, we can also infer growth potential through profitability metrics, which often accompany scaling operations. While APH exhibits superior net and EBITDA margins (18.49% net margin, 29.84% EBITDA margin) compared to ACN (10.65% net margin, 16.8% EBITDA margin), these higher margins in conjunction with its rapid revenue growth indicate a highly efficient and expanding business. This combination of aggressive revenue growth and strong profitability suggests APH has considerable forward momentum and the potential for continued strong performance, making it the preferred choice for growth-oriented investors looking for dynamic expansion in the market.

ACN vs APH profitability

When evaluating ACN vs APH profitability, Amphenol Corporation (APH) clearly demonstrates superior operational efficiency and margin performance. APH boasts a net margin of 18.49% and an EBITDA margin of 29.84%, both significantly higher than Accenture plc’s (ACN) net margin of 10.65% and EBITDA margin of 16.8%. These figures indicate that APH is more effective at converting its revenue into actual profit, suggesting a stronger business model or better cost management within its operations. While ROE data is not available for either company, APH’s higher margins point to a more profitable core business on a per-revenue basis.

However, a different picture emerges when considering free cash flow (FCF) yield, which provides insight into how much cash a company generates relative to its market value. ACN shows a strong FCF yield of 10.47%, indicating that it generates a substantial amount of cash that can be used for reinvestment, debt repayment, or shareholder returns. APH, on the other hand, has a much lower FCF yield of 2.39%. This implies that while APH has higher profit margins, ACN is more efficient at turning those profits into deployable cash, suggesting that ACN generates more cash relative to its enterprise value, which could be attractive for investors focused on cash generation and financial flexibility.

Analyst ratings: ACN vs APH

The analyst consensus provides a strong indication of market sentiment, and in the acn vs aph stock comparison 2026, Accenture (ACN) holds a more favorable position. Out of 53 analysts covering ACN, a significant 73.6% have issued a “Buy” rating, contributing to an overall “Buy” consensus. Their collective price target for ACN stands at $299.92, representing a substantial upside potential of +54.6% from its current price of $194. This high percentage of buy ratings and considerable upside suggests strong confidence among experts regarding ACN’s future performance and valuation.

Amphenol Corporation (APH) also garners a “Buy” consensus, but with less enthusiastic backing. Among the 29 analysts covering APH, 51.7% recommend a “Buy,” which is notably lower than ACN’s percentage. The consensus price target for APH is $176.88, indicating a more modest upside of +18.7% from its current price of $148.96. While APH is still viewed positively, the higher proportion of “Buy” ratings and the significantly larger projected upside for ACN clearly indicate that analysts collectively prefer Accenture for its potential returns in the current market environment.

Should I buy ACN or APH stock in 2026?

Deciding whether you should buy ACN or APH stock in 2026 depends heavily on your investment priorities and risk tolerance. For growth-oriented investors seeking dynamic expansion, Amphenol (APH) presents a compelling case. Its remarkable year-over-year revenue growth of +51.7% demonstrates significant market penetration and robust demand for its solutions, far outpacing Accenture’s (ACN) 7.4% growth. If your primary goal is to capitalize on companies experiencing rapid top-line expansion and operational efficiency, despite a higher valuation, APH might align better with your strategy.

Conversely, for value investors or those prioritizing a stronger margin of safety, Accenture (ACN) stands out. ACN’s P/E ratio of 15.58x and P/B ratio of 3.84x are considerably lower than APH’s 42.75x and 13.61x, respectively, suggesting ACN is trading at a more attractive price relative to its earnings and assets. Furthermore, ACN’s discounted cash flow (DCF) model indicates a +10.4% upside, while APH shows a significant -42.9% downside. These valuation metrics, coupled with ACN’s stronger analyst target upside of +54.6%, make it a more appealing choice for those focused on acn vs aph fundamentals and valuation to identify undervalued opportunities.

Regarding income, neither ACN nor APH are particularly strong dividend payers, with both offering minimal yields. However, ACN’s dividend yield of 0.03% is marginally higher than APH’s 0.01%, meaning ACN has a slight edge for investors who consider even a nominal dividend important. Ultimately, if you prioritize strong growth momentum and higher profitability margins, APH could be your pick. If you lean towards a more favorable valuation, higher analyst conviction, and stronger free cash flow generation, ACN offers a more balanced investment proposition in 2026. This is not investment advice; always conduct your own thorough research.

More ACN and APH comparisons

ACN full stock analysis · APH full stock analysis · All stock comparisons

FAQ: ACN vs APH